After the US Food and Drug Administration approval in 2002 of the first ever fully human mAb drug (AbbVie’s Humira (adalimumab)), fully human mAbs rapidly became the gold standard of mAb-based ...

I-Mab Biopharma (‘I-Mab’), headquartered in Shanghai, is different. From its inception in 2015, the company has been focused exclusively on discovering and developing innovative biologics ...

The MAB Young Scientists Awards targets young researchers carrying out interdisciplinary research in line with UNESCO's Man and the Biosphere (MAB) Programme. Priority is given to projects carried out ...